glp 1 free trial Clinical trials suggest GLP-1s may improve fertility in men with obesity Lilly orforglipron oral GLP-1 phase

, Egecioglu, E

The SELECT trial result - 20% reduction in major cardiovascular events with weekly semaglutide 2.4mg in adults with established cardiovascular disease plus overweight/obesity - was the first time a weight-loss medication demonstrated cardiovascular outcome benefits in a major randomized controlled trial

Semaglutide: The One Youve Probably Already Heard Of Semaglutide mimics GLP-1, a gut hormone your body releases after eating that slows digestion and tells your brain youre full

Understanding how GLP-1 works in the brain has become increasingly relevant as GLP-1 receptor agonist medicationslicensed in the UK for type 2 diabetes and weight managementproduce neurological effects including appetite suppression and potential neuroprotective benefits

T., & Drogemuller, C

Stauffer, C